Delivery Order SPE2DB22D2206-SPE2DB25FFZ72
Award Date
3/7/25
Potential Completion Date
3/10/25
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of XHANCE 93 MCG Nasal Spray 16ML. The $4,796.97 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a wide range of medical commodities to support military treatment programs...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,161.81 firm fixed-price delivery order is for the supply of XHANCE 93 MCG NASAL SPRAY 16ML, a specialty pharmaceutical product. The contract has an ultimate completion date of December 18, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,755.30, is for the delivery of the drug XHANCE 93 MCG NASAL SPRAY 16ML. The contract is a firm-fixed-price, Indefinite Delivery Contract (IDC) that runs through February 12, 2025. This IDC, valued at $999,999,999, serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,888.95, is for the supply of XHANCE 93 MCG NASAL SPRAY 16ML, a pharmaceutical product. The contract is a firm fixed-price delivery order, with a completion date of February 26, 2025. The contract is not designated as a set-aside and was open to full and open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. The contract, valued at $3,783.52, is for the delivery of XHANCE 93 MCG NASAL SPRAY 16ML. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of January 27, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product XHANCE 93 MCG NASAL SPRAY 16ML. The contract has a ceiling value of $1,026.39 and a period of performance through April 15, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA that serves as the primary vehicle for the company to deliver...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of medical products including the medication XHANCE 93 MCG NASAL SPRAY 16ML. The contract has a ceiling value of $1,144.68 and a period of performance through April 15, 2024. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This contract award, with award ID SPE2DB22D3004|SPE2DB24FRK81, is for the delivery of XHANCE 93 MCG NASAL SPRAY 16ML to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $2,344.96 and is a Firm Fixed Price Delivery Order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. This award is not associated with a set-aside program. The contract has an ultimate completion date of August 13, 2024 and was awarded on August 12,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of a pharmaceutical product - QNASL 80 MCG NASAL SPRAY 10.6GM. The contract, valued at $2,055.12, is a firm fixed-price delivery order with a completion date of November 12, 2024. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award is a delivery order valued at $8,206.19 issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded by the Defense Logistics Agency (DLA), is for the delivery of 4,566,167,270 units of Fluticasone Prop HFA 110 MCG 12GM, a respiratory medication, with an ultimate completion date of October 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...